Litcius/Paper detail

Current Clinical Trial Landscape of OX40 Agonists

Rashi Yadav, William L. Redmond

2022Current Oncology Reports44 citationsDOI

Topics & Concepts

MedicineBlockadeImmunotherapyImmune checkpointT cellAgonistOncologyCancer researchInternal medicineReceptorImmune systemImmunologyCancerCancer Immunotherapy and BiomarkersImmune Cell Function and InteractionImmunotherapy and Immune Responses
Current Clinical Trial Landscape of OX40 Agonists | Litcius